Regional cerebral blood flow and cerebrospinal fluid amino acid analysis in elderly dementia

Brain and Nerve

Volumn 50, Issue 11, 1998, Pages 1018-1021

  Oishi, Minoru ^a   Mochizuki, Yoko ^a   Sanuki, Eiichi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Amino acid; Cerebral blood flow; Cerebrospinal fluid; Dementia

Indexed keywords

4 AMINOBUTYRIC ACID;

ALCOHOLISM; ALZHEIMER DISEASE; AMINO ACID ANALYSIS; ARTICLE; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; NEUROLOGIC DISEASE; NEUROTRANSMISSION;

ALCOHOLISM; ALZHEIMER DISEASE; AMINO ACIDS; AMINOBUTYRIC ACIDS; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; DEMENTIA, VASCULAR; GLUTAMIC ACID; HUMANS; MIDDLE AGED; REGIONAL BLOOD FLOW;

EID: 0031788144     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Melgaard B, Henriksen L. Ahlgren P, et al: Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography. Acta Neurol Scand 82: 87-93, 1990
2. Erbas B, Bekdik C, Erbengi G, et al: Regional cerebral blood flow changes in chronic alcoholism using Tc-99m HMPAO SPECT: Comparison with CT parameters. Clin Nucl Med 17: 123-127, 1992
3. Syed GMS, Eagger S, O'Brien J, et al: Patterns of regional cerebral blood flow in Alzheimer's disease. Nucl Med Com 13: 656-663, 1992
4. Kawabata K, Tachibana H, Sugita M, et al: A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease. Clin Nucl Med 18: 329-336, 1993
5. Nicolás JM, Catafau AM, Estruch R, et al: Regional cerebral blood flow-SPECT in chronic alcoholism: Relation to neuropsychological testing. J Nucl Med 34: 1452-1459, 1993
6. Claus JJ, van Harskamp F, Breteler MMB, et al: The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease. Neurology 44: 454 -461, 1994
7. Talbot PR, Testa HJ: The value of SPET imaging in dementia. Nucl Med Com 16: 425-437, 1995
8. Newberg AB, Alavi A, Payer F: Single photon emission computed tomography in Alzheimer's disease and related disorders. Neuroimaging Clin North Am 5: 103-123, 1995
9. Oishi M, Mochizuki Y, Hara M. et al: Central motor conduction time in patients with periventricular lucencies. J Neurol Sci 142: 30-35, 1996
10. Oishi M, Mochizuki Y, Takasu T: Cerebral blood flow and cerebrovascular response to acetazolamide in patients with chronic alcoholism. J Neurol Neurosurg Psychiatry 63: 100-102, 1997
11. Oishi M, Mochizuki Y, Takasu T: Blood flow differences between leuko-araiosis with and without lacunar infarction. Can J Neurol Sci 25: 70-75, 1998
12. Degrell I, Hellsing K, Nagy E, et al: Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multiinfarct dementia. Arch Gerontol Geriatr 9: 123-135, 1989
13. Dodd PR, Scott HL, Westphalen RI: Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem Int 25: 203-219, 1994
14. Thomas RJ: Excitatory amino acids in health and disease. J Am Geriatr Soc 43: 1279-1289, 1995
15. Mochizuki Y, Oishi M, Hara M, et al: Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia. Ann Clin Lab Sci 26: 275-278, 1996
16. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN international workshop. Neurology 43: 250-260, 1993
17. McKhann G, Drachman D, Folstein M. et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 34: 939-944, 1984
18. Schuckit MA. Heizer JE, Cottler JE, et al: Substance-related disorders. In Diagnostic and Statistical Manual of Mental Disorders, edited by Frances A. Pincus HA, First MB, American Psychiatric Association, Washington, DC, pp175-272, 1994
19. Dingledine R, McBain CJ: Excitatory amino acid transmitters In Basic Neurochemistry, 5th edition, edited by Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, Raven Press, New York, pp367-387, 1994
20. Delorey TM, Olsen RW: GABA and glycine. In Basic Neurochemistry, 5th edition, edited by Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, Raven Press, New York, pp389-399, 1994
21. Szatkowski M, Attwell D: Triggering and execution of neuronal death in brain ischemia: Two phases of glutamate release by different mechanisms. Trends Neurosci 17: 359-365, 1994
22. Zhang J, Benveniste H, Klitzman B, et al: Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion. Stroke 26: 298-304, 1995
23. Hegstad E, Berg-Johnsen J, Haugstad TS, et al: Amino-acid release from human cerebral cortex during simulated ischaemia in vitro. Acta Neurochir (Wien) 138: 234-241, 1996
24. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105-111, 1986
25. Choi DW, Rothman SM: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13: 171-182, 1990
26. Hamberger A, Nyström B, Silvenius H, et al: The contribution from the choroid plexus and the periventricular CNS to amino acids and proteins in the human CSF. Neurochem Res 15: 307-312, 1990
27. Mathew RJ, Wilson WH: Substance abuse and cerebral blood flow. Am J Psychiatry 148: 292-305, 1991